• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

棕榈酰化 TIM-3 促进免疫衰竭并抑制抗肿瘤免疫。

Palmitoylation of TIM-3 promotes immune exhaustion and restrains antitumor immunity.

机构信息

Key Laboratory for Experimental Teratology of Ministry of Education and Department of Immunology, School of Basic Medical Sciences, Qilu Hospital, Cheeloo Medical College, Shandong University, 250012 Jinan, Shandong, China.

Department of Hepatology, Qilu Hospital, Cheeloo Medical College, Shandong University, 250012 Jinan, Shandong, China.

出版信息

Sci Immunol. 2024 Nov 15;9(101):eadp7302. doi: 10.1126/sciimmunol.adp7302.

DOI:10.1126/sciimmunol.adp7302
PMID:39546589
Abstract

T cell immunoglobulin and mucin domain-containing protein 3 (TIM-3) is an immune checkpoint that has critical roles in immune exhaustion. However, little is known about the mechanisms that regulate TIM-3 surface expression and turnover. Here, we report that human TIM-3 is palmitoylated by the palmitoyltransferase DHHC9 at residue cysteine 296 (Cys). Palmitoylation stabilized TIM-3 by preventing binding to E3 ubiquitin ligase HRD1, thereby suppressing its polyubiquitination and degradation. DHHC9 knockdown attenuated chimeric antigen receptor T (CAR-T) cell exhaustion, and a peptidic inhibitor of TIM-3 palmitoylation accelerated TIM-3 degradation and enhanced antitumor immunity mediated by CAR-T cells and natural killer (NK) cells. In hepatocellular carcinoma, DHHC9 expression correlated with TIM-3 expression in CD8 T cells and NK cells, and high DHHC9 expression was associated with shorter survival in patients with high TIM-3. These findings demonstrate that palmitoylation of TIM-3 catalyzed by DHHC9 promotes its stability, resulting in immune exhaustion and impaired antitumor immunity.

摘要

T 细胞免疫球蛋白和粘蛋白结构域蛋白 3(TIM-3)是一种免疫检查点,在免疫衰竭中具有关键作用。然而,关于调节 TIM-3 表面表达和周转的机制知之甚少。在这里,我们报告人类 TIM-3 被棕榈酰转移酶 DHHC9 在半胱氨酸残基 296(Cys)处棕榈酰化。棕榈酰化通过防止与 E3 泛素连接酶 HRD1 结合来稳定 TIM-3,从而抑制其多泛素化和降解。DHHC9 敲低减弱了嵌合抗原受体 T(CAR-T)细胞衰竭,TIM-3 棕榈酰化的肽抑制剂加速了 TIM-3 降解,并增强了由 CAR-T 细胞和自然杀伤(NK)细胞介导的抗肿瘤免疫。在肝细胞癌中,DHHC9 在 CD8 T 细胞和 NK 细胞中的表达与 TIM-3 的表达相关,高 DHHC9 表达与高 TIM-3 患者的生存时间较短相关。这些发现表明,DHHC9 催化的 TIM-3 棕榈酰化促进其稳定性,导致免疫衰竭和抗肿瘤免疫受损。

相似文献

1
Palmitoylation of TIM-3 promotes immune exhaustion and restrains antitumor immunity.棕榈酰化 TIM-3 促进免疫衰竭并抑制抗肿瘤免疫。
Sci Immunol. 2024 Nov 15;9(101):eadp7302. doi: 10.1126/sciimmunol.adp7302.
2
Identification of a small-molecule Tim-3 inhibitor to potentiate T cell-mediated antitumor immunotherapy in preclinical mouse models.在临床前小鼠模型中鉴定一种小分子Tim-3抑制剂以增强T细胞介导的抗肿瘤免疫疗法。
Sci Transl Med. 2023 Nov 15;15(722):eadg6752. doi: 10.1126/scitranslmed.adg6752.
3
Palmitoylation enhances the stability of porcine epidemic diarrhea virus spike protein by antagonizing its degradation via chaperone-mediated autophagy to facilitate viral proliferation.棕榈酰化通过拮抗伴侣介导的自噬对猪流行性腹泻病毒刺突蛋白的降解来增强其稳定性,从而促进病毒增殖。
J Virol. 2025 Jun 17;99(6):e0034725. doi: 10.1128/jvi.00347-25. Epub 2025 May 22.
4
Riplet promotes lipid metabolism changes associated with CD8 T cell exhaustion and anti-PD-1 resistance in hepatocellular carcinoma.Riplet促进与肝细胞癌中CD8 T细胞耗竭和抗PD-1耐药相关的脂质代谢变化。
Sci Immunol. 2025 Jun 27;10(108):eado3485. doi: 10.1126/sciimmunol.ado3485.
5
Anti-atherogenic immune checkpoint TIM-3 as a promising pharmacologic target toward ischemic heart diseases: a prospective review.抗动脉粥样硬化免疫检查点TIM-3作为缺血性心脏病的一个有前景的药理学靶点:前瞻性综述
Mol Biol Rep. 2025 Jun 23;52(1):623. doi: 10.1007/s11033-025-10729-3.
6
Lymphocyte exhaustion in hepatocellular carcinoma: a dynamic evolution across disease stages.肝细胞癌中的淋巴细胞耗竭:疾病各阶段的动态演变
Front Immunol. 2025 Jun 6;16:1611365. doi: 10.3389/fimmu.2025.1611365. eCollection 2025.
7
WTAP Accelerates Exhaustion of CD8 T Cells and Progression of Hepatocellular Carcinoma by Promoting m6A Modification and Translation of PD1 mRNA.WTAP通过促进m6A修饰和PD1 mRNA的翻译加速CD8 T细胞耗竭和肝细胞癌进展。
Mediators Inflamm. 2025 Jun 18;2025:6217272. doi: 10.1155/mi/6217272. eCollection 2025.
8
Ammonia Suppresses the Antitumor Activity of Natural Killer Cells and T Cells by Decreasing Mature Perforin.氨通过降低成熟穿孔素水平来抑制自然杀伤细胞和T细胞的抗肿瘤活性。
Cancer Res. 2025 Jul 2;85(13):2448-2467. doi: 10.1158/0008-5472.CAN-24-0749.
9
The CP123L protein of African swine fever virus is a membrane-associated, palmitoylated protein required for viral replication.非洲猪瘟病毒的CP123L蛋白是一种与膜相关的、经棕榈酰化修饰的蛋白,是病毒复制所必需的。
J Virol. 2025 Jan 31;99(1):e0144524. doi: 10.1128/jvi.01445-24. Epub 2024 Dec 23.
10
Expression of B7-H3 and TIM-3 in gastric-type endocervical adenocarcinoma: prevalence, association with PD-L1 expression, and prognostic significance.B7-H3 和 TIM-3 在胃型宫颈内膜腺癌中的表达:流行率、与 PD-L1 表达的相关性及预后意义。
J Pathol Clin Res. 2024 Jan;10(1):e345. doi: 10.1002/cjp2.345. Epub 2023 Oct 5.

引用本文的文献

1
Pharmacological Targeting of DHHC9-Mediated STRN4 Palmitoylation to Suppress YAP-Driven Cancer Metastasis.靶向DHHC9介导的STRN4棕榈酰化以抑制YAP驱动的癌症转移的药理学研究
J Cell Mol Med. 2025 Sep;29(17):e70815. doi: 10.1111/jcmm.70815.
2
TLR9-Driven S-Palmitoylation in Dendritic Cells Reveals Immune and Metabolic Protein Targets.树突状细胞中TLR9驱动的S-棕榈酰化揭示免疫和代谢蛋白靶点。
Eur J Immunol. 2025 Aug;55(8):e70039. doi: 10.1002/eji.70039.
3
Palmitic acid and palmitoylation in cancer: Understanding, insights, and challenges.
癌症中的棕榈酸与棕榈酰化:认识、见解与挑战
Innovation (Camb). 2025 Apr 29;6(8):100918. doi: 10.1016/j.xinn.2025.100918. eCollection 2025 Aug 4.
4
Multi-omics-based construction of a palmitoylation-driven prognostic model reveals tumor immune phenotypes in osteosarcoma.基于多组学构建棕榈酰化驱动的预后模型揭示骨肉瘤的肿瘤免疫表型
Discov Oncol. 2025 Aug 13;16(1):1544. doi: 10.1007/s12672-025-03364-8.
5
Application of Immune Checkpoint Inhibitors in Cancer.免疫检查点抑制剂在癌症中的应用。
MedComm (2020). 2025 Aug 10;6(8):e70176. doi: 10.1002/mco2.70176. eCollection 2025 Aug.
6
Potential therapeutic target in oncology: Protein palmitoylation (Review).肿瘤学中的潜在治疗靶点:蛋白质棕榈酰化(综述)
Oncol Rep. 2025 Oct;54(4). doi: 10.3892/or.2025.8950. Epub 2025 Jul 19.
7
Post-translational modifications of cancer immune checkpoints: mechanisms and therapeutic strategies.癌症免疫检查点的翻译后修饰:机制与治疗策略
Mol Cancer. 2025 Jul 8;24(1):193. doi: 10.1186/s12943-025-02397-5.
8
Causal relationships between immune-related adverse events, immune cell characteristics, and plasma metabolites: insights from Mendelian randomization study.免疫相关不良事件、免疫细胞特征与血浆代谢物之间的因果关系:孟德尔随机化研究的见解
Discov Oncol. 2025 Jul 1;16(1):1210. doi: 10.1007/s12672-025-02607-y.
9
Exploring the role of protein palmitoylation in cancer progression and therapy: a comprehensive bibliometric study (2004-2024).探索蛋白质棕榈酰化在癌症进展和治疗中的作用:一项全面的文献计量学研究(2004 - 2024年)
Discov Oncol. 2025 Jul 1;16(1):1221. doi: 10.1007/s12672-025-03059-0.
10
[Research Progress and Applications of ZDHHC-mediated Protein Palmitoylation 
in the Development and Immune Escape of Non-small Cell Lung Cancer].[ZDHHC介导的蛋白质棕榈酰化在非小细胞肺癌发生发展及免疫逃逸中的研究进展与应用]
Zhongguo Fei Ai Za Zhi. 2025 Apr 20;28(4):319-324. doi: 10.3779/j.issn.1009-3419.2025.102.15.